ADMA Biologics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses Block & Leviton is investigating ADMA Biologics (Nasdaq: ADMA) for potential securities fraud. Investors who have lost money should contact the firm.